Short answer
EyePoint, Inc. (EYPT) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 financial results released for quarter ended June 30, 2026.
EyePoint, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 financial results released for quarter ended June 30, 2026
- Updated investor presentation provides additional business and corporate information
- Investors should review Exhibits 99.1 and 99.2 for detailed results and updates
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $0.5M vs $5.3M, reflecting reduced license-related revenue and limited commercial sales
- Operating expenses rose to $97.9M from $67.6M, driven by DURAVYU Phase 3 trials and manufacturing scale-up
- Net loss widened to $94.5M, or $1.09 per share, from $59.4M, or $0.85 per share
- Cash and investments fell to $180M from $223M at March 31, 2026, with runway projected into Q4 2027
- Key catalysts: LUGANO topline data expected August 2026, LUCIA in Q4 2026, and DME data in Q4 2027
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other EyePoint, Inc. 8-K filings
Get the next EYPT 8-K as it lands
Follow EYPT for push alerts, or ask the research agent what this filing means.